Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. [electronic resource]
Publication details: Therapeutic advances in gastroenterology 2020Description: 1756284819897531 p. digitalISSN:- 1756-283X
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.